Cargando…

Differential Diagnosis of Malignant Lymphadenopathy Using Flow Cytometry on Fine Needle Aspirate: Report on 269 Cases

Introduction: Fine needle aspiration (FNA) is frequently the first noninvasive test used for the diagnostic workup of lymphadenopathy. There have been many studies showing its usefulness, especially in conjunction with other techniques for the diagnosis of lymphoma, but it remains inferior to histol...

Descripción completa

Detalles Bibliográficos
Autores principales: Griesel, Carla, Desmirean, Minodora, Esterhuizen, Tonya, Pasca, Sergiu, Petrushev, Bobe, Selicean, Cristina, Roman, Andrei, Fetica, Bogdan, Teodorescu, Patric, Swanepoel, Carmen, Tomuleasa, Ciprian, Grewal, Ravnit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019747/
https://www.ncbi.nlm.nih.gov/pubmed/31968576
http://dx.doi.org/10.3390/jcm9010283
_version_ 1783497590856220672
author Griesel, Carla
Desmirean, Minodora
Esterhuizen, Tonya
Pasca, Sergiu
Petrushev, Bobe
Selicean, Cristina
Roman, Andrei
Fetica, Bogdan
Teodorescu, Patric
Swanepoel, Carmen
Tomuleasa, Ciprian
Grewal, Ravnit
author_facet Griesel, Carla
Desmirean, Minodora
Esterhuizen, Tonya
Pasca, Sergiu
Petrushev, Bobe
Selicean, Cristina
Roman, Andrei
Fetica, Bogdan
Teodorescu, Patric
Swanepoel, Carmen
Tomuleasa, Ciprian
Grewal, Ravnit
author_sort Griesel, Carla
collection PubMed
description Introduction: Fine needle aspiration (FNA) is frequently the first noninvasive test used for the diagnostic workup of lymphadenopathy. There have been many studies showing its usefulness, especially in conjunction with other techniques for the diagnosis of lymphoma, but it remains inferior to histological examination. The data regarding this subject have mostly been reported mostly from first-world countries, but are scarce for emerging economies. Thus, the current study assesses the agreement between fine needle aspiration flow cytometry (FNA FC) and histology in the aforementioned region. Material and Methods: We conducted a retrospective study including the FNA FC adenopathy diagnoses made between January 2011 and December 2016 at the Tygerberg Hospital, Cape Town, South Africa. Additional variables included were the histological diagnosis, sex and age of the included patients. Results: In the descriptive part of the current study, 269 FNA FC samples were included. The most frequent diagnoses made on these were represented by B-cell lymphoma, reactive adenopathy, no abnormality detected (NAD), and non-hematological malignancy. In the analytical part of the current study, there were 115 cases included that had both valid FNA FC and histological diagnoses. It could be observed that FNA FC can correctly diagnose B-cell lymphoma in most cases, but it is a poor diagnostic tool especially for Hodgkin lymphoma in this setting as only a four-color flow cytometer was available for diagnosis. Moreover, FNA FC diagnosis of reactive adenopathy and of no abnormalities detected was shown to frequently hide a malignant disease. Conclusion: In countries with scarce resources, FNA FC represents a useful diagnostic tool in the case of B-cell lymphoma, but may misdiagnose reactive adenopathy. Thus, FNA FC should be used in a case-specific manner, in addition to as a screening tool, with the knowledge that in cases with a high clinical suspicion of lymphoma, histological diagnosis is a necessity.
format Online
Article
Text
id pubmed-7019747
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70197472020-03-09 Differential Diagnosis of Malignant Lymphadenopathy Using Flow Cytometry on Fine Needle Aspirate: Report on 269 Cases Griesel, Carla Desmirean, Minodora Esterhuizen, Tonya Pasca, Sergiu Petrushev, Bobe Selicean, Cristina Roman, Andrei Fetica, Bogdan Teodorescu, Patric Swanepoel, Carmen Tomuleasa, Ciprian Grewal, Ravnit J Clin Med Article Introduction: Fine needle aspiration (FNA) is frequently the first noninvasive test used for the diagnostic workup of lymphadenopathy. There have been many studies showing its usefulness, especially in conjunction with other techniques for the diagnosis of lymphoma, but it remains inferior to histological examination. The data regarding this subject have mostly been reported mostly from first-world countries, but are scarce for emerging economies. Thus, the current study assesses the agreement between fine needle aspiration flow cytometry (FNA FC) and histology in the aforementioned region. Material and Methods: We conducted a retrospective study including the FNA FC adenopathy diagnoses made between January 2011 and December 2016 at the Tygerberg Hospital, Cape Town, South Africa. Additional variables included were the histological diagnosis, sex and age of the included patients. Results: In the descriptive part of the current study, 269 FNA FC samples were included. The most frequent diagnoses made on these were represented by B-cell lymphoma, reactive adenopathy, no abnormality detected (NAD), and non-hematological malignancy. In the analytical part of the current study, there were 115 cases included that had both valid FNA FC and histological diagnoses. It could be observed that FNA FC can correctly diagnose B-cell lymphoma in most cases, but it is a poor diagnostic tool especially for Hodgkin lymphoma in this setting as only a four-color flow cytometer was available for diagnosis. Moreover, FNA FC diagnosis of reactive adenopathy and of no abnormalities detected was shown to frequently hide a malignant disease. Conclusion: In countries with scarce resources, FNA FC represents a useful diagnostic tool in the case of B-cell lymphoma, but may misdiagnose reactive adenopathy. Thus, FNA FC should be used in a case-specific manner, in addition to as a screening tool, with the knowledge that in cases with a high clinical suspicion of lymphoma, histological diagnosis is a necessity. MDPI 2020-01-20 /pmc/articles/PMC7019747/ /pubmed/31968576 http://dx.doi.org/10.3390/jcm9010283 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Griesel, Carla
Desmirean, Minodora
Esterhuizen, Tonya
Pasca, Sergiu
Petrushev, Bobe
Selicean, Cristina
Roman, Andrei
Fetica, Bogdan
Teodorescu, Patric
Swanepoel, Carmen
Tomuleasa, Ciprian
Grewal, Ravnit
Differential Diagnosis of Malignant Lymphadenopathy Using Flow Cytometry on Fine Needle Aspirate: Report on 269 Cases
title Differential Diagnosis of Malignant Lymphadenopathy Using Flow Cytometry on Fine Needle Aspirate: Report on 269 Cases
title_full Differential Diagnosis of Malignant Lymphadenopathy Using Flow Cytometry on Fine Needle Aspirate: Report on 269 Cases
title_fullStr Differential Diagnosis of Malignant Lymphadenopathy Using Flow Cytometry on Fine Needle Aspirate: Report on 269 Cases
title_full_unstemmed Differential Diagnosis of Malignant Lymphadenopathy Using Flow Cytometry on Fine Needle Aspirate: Report on 269 Cases
title_short Differential Diagnosis of Malignant Lymphadenopathy Using Flow Cytometry on Fine Needle Aspirate: Report on 269 Cases
title_sort differential diagnosis of malignant lymphadenopathy using flow cytometry on fine needle aspirate: report on 269 cases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019747/
https://www.ncbi.nlm.nih.gov/pubmed/31968576
http://dx.doi.org/10.3390/jcm9010283
work_keys_str_mv AT grieselcarla differentialdiagnosisofmalignantlymphadenopathyusingflowcytometryonfineneedleaspiratereporton269cases
AT desmireanminodora differentialdiagnosisofmalignantlymphadenopathyusingflowcytometryonfineneedleaspiratereporton269cases
AT esterhuizentonya differentialdiagnosisofmalignantlymphadenopathyusingflowcytometryonfineneedleaspiratereporton269cases
AT pascasergiu differentialdiagnosisofmalignantlymphadenopathyusingflowcytometryonfineneedleaspiratereporton269cases
AT petrushevbobe differentialdiagnosisofmalignantlymphadenopathyusingflowcytometryonfineneedleaspiratereporton269cases
AT seliceancristina differentialdiagnosisofmalignantlymphadenopathyusingflowcytometryonfineneedleaspiratereporton269cases
AT romanandrei differentialdiagnosisofmalignantlymphadenopathyusingflowcytometryonfineneedleaspiratereporton269cases
AT feticabogdan differentialdiagnosisofmalignantlymphadenopathyusingflowcytometryonfineneedleaspiratereporton269cases
AT teodorescupatric differentialdiagnosisofmalignantlymphadenopathyusingflowcytometryonfineneedleaspiratereporton269cases
AT swanepoelcarmen differentialdiagnosisofmalignantlymphadenopathyusingflowcytometryonfineneedleaspiratereporton269cases
AT tomuleasaciprian differentialdiagnosisofmalignantlymphadenopathyusingflowcytometryonfineneedleaspiratereporton269cases
AT grewalravnit differentialdiagnosisofmalignantlymphadenopathyusingflowcytometryonfineneedleaspiratereporton269cases